Evidence map›Paper›PMID 37292694›Full record

ArticleResearch square2023

Integrated multimodal cell atlas of Alzheimer's disease.

Mariano I Gabitto, Kyle J Travaglini, Victoria M Rachleff, Eitan S Kaplan, Brian Long, Jeanelle Ariza, Yi Ding, Joseph T Mahoney, Nick Dee, Jeff Goldy and 81 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 63 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

91 authors at 6 institutions in 1 country.

Mariano I GabittoAllen Institute for Brain Science, Seattle, WA, 98109.
Kyle J TravagliniAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0003-3164-6448
Victoria M RachleffAllen Institute for Brain Science, Seattle, WA, 98109.
Eitan S KaplanAllen Institute for Brain Science, Seattle, WA, 98109.
Brian LongAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-7793-5969
Jeanelle ArizaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Yi DingAllen Institute for Brain Science, Seattle, WA, 98109.
Joseph T MahoneyAllen Institute for Brain Science, Seattle, WA, 98109.
Nick DeeAllen Institute for Brain Science, Seattle, WA, 98109.
Jeff GoldyAllen Institute for Brain Science, Seattle, WA, 98109.
Erica J MeliefDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Krissy BrounerAllen Institute for Brain Science, Seattle, WA, 98109.
John CamposDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Ambrose J CarrChan Zuckerberg Initiative, Redwood City, CA 94063.
Tamara CasperAllen Institute for Brain Science, Seattle, WA, 98109.
Rushil ChakrabartyAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0003-1722-8557
Michael ClarkAllen Institute for Brain Science, Seattle, WA, 98109.
Jazmin ComposAllen Institute for Brain Science, Seattle, WA, 98109.
Jonah CoolChan Zuckerberg Initiative, Redwood City, CA 94063.
Nasmil J Valera CuevasAllen Institute for Brain Science, Seattle, WA, 98109.
Rachel DalleyAllen Institute for Brain Science, Seattle, WA, 98109.
Martin DarvasDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Song-Lin DingAllen Institute for Brain Science, Seattle, WA, 98109.
Tim DolbeareAllen Institute for Brain Science, Seattle, WA, 98109.
Christine L Mac DonaldDepartment of Neurological Surgery, University of Washington, Seattle, WA 98104.
Tom EgdorfAllen Institute for Brain Science, Seattle, WA, 98109.
Luke EspositoAllen Institute for Brain Science, Seattle, WA, 98109.
Rebecca FerrerAllen Institute for Brain Science, Seattle, WA, 98109.
Rohan GalaAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0003-1872-0957
Amanda GaryAllen Institute for Brain Science, Seattle, WA, 98109.
Jessica GloeAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0001-8343-3423
Nathan GuilfordAllen Institute for Brain Science, Seattle, WA, 98109.
Junitta GuzmanAllen Institute for Brain Science, Seattle, WA, 98109.
Windy HoAllen Institute for Brain Science, Seattle, WA, 98109.
Tim JarksyAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-4399-539X
Nelson JohansenAllen Institute for Brain Science, Seattle, WA, 98109.
Brian E KalmbachAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0003-3136-8097
Lisa M KeeneDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Sarah KhawandDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Mitch KilgoreDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.ORCID 0000-0003-1101-6924
Amanda KirklandDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Michael KunstAllen Institute for Brain Science, Seattle, WA, 98109.
Brian R LeeAllen Institute for Brain Science, Seattle, WA, 98109.
Jocelin MaloneAllen Institute for Brain Science, Seattle, WA, 98109.
Zoe MaltzerAllen Institute for Brain Science, Seattle, WA, 98109.
Naomi MartinAllen Institute for Brain Science, Seattle, WA, 98109.
Rachel McCueAllen Institute for Brain Science, Seattle, WA, 98109.
Delissa McMillenAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-3413-4424
Emma MeyerdierksAllen Institute for Brain Science, Seattle, WA, 98109.
Kelly P MeyersKaiser Permanente Washington Research Institute, Seattle, WA, 98101.
Tyler MollenkopfAllen Institute for Brain Science, Seattle, WA, 98109.
Mark MontineDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Amber L NolanDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Julie NyhusAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-2006-8235
Paul A OlsenAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0001-8132-3722
Maiya PaclebDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Thanh PhamAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-4738-5062
Christina Alice PomAllen Institute for Brain Science, Seattle, WA, 98109.
Nadia PostupnaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Augustin RuizAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-8361-5152
Aimee M SchantzDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.ORCID 0009-0006-2634-4970
Staci A SorensenAllen Institute for Brain Science, Seattle, WA, 98109.
Brian StaatsAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-3818-3792
Matt SullivanAllen Institute for Brain Science, Seattle, WA, 98109.
Susan M SunkinAllen Institute for Brain Science, Seattle, WA, 98109.
Carol ThompsonAllen Institute for Brain Science, Seattle, WA, 98109.
Michael TieuAllen Institute for Brain Science, Seattle, WA, 98109.
Jonathan TingAllen Institute for Brain Science, Seattle, WA, 98109.
Amy TorkelsonAllen Institute for Brain Science, Seattle, WA, 98109.
Tracy TranAllen Institute for Brain Science, Seattle, WA, 98109.
Ming-Qiang WangAllen Institute for Brain Science, Seattle, WA, 98109.
Jack WatersAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-2312-4183
Angela M WilsonDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
David HaynorDepartment of Radiology, University of Washington, Seattle, WA 98014.
Nicole GattoKaiser Permanente Washington Research Institute, Seattle, WA, 98101.
Suman JayadevDepartment of Neurology, University of Washington, Seattle, WA 98104.ORCID 0000-0003-3164-9665
Shoaib MuftiAllen Institute for Brain Science, Seattle, WA, 98109.
Lydia NgAllen Institute for Brain Science, Seattle, WA, 98109.
Shubhabrata MukherjeeDepartment of Medicine, University of Washington, Seattle, WA 98104.ORCID 0000-0003-2522-2884
Paul K CraneDepartment of Medicine, University of Washington, Seattle, WA 98104.
Caitlin S LatimerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
Boaz P LeviAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-8346-872X
Kimberly SmithAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-3142-1970
Jennie L CloseAllen Institute for Brain Science, Seattle, WA, 98109.
Jeremy A MillerAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0003-4549-588X
Rebecca D HodgeAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-5784-9668
Eric B LarsonDepartment of Medicine, University of Washington, Seattle, WA 98104.
Thomas J GrabowskiDepartment of Radiology, University of Washington, Seattle, WA 98014.
Michael HawrylyczAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0002-5741-8024
C Dirk KeeneDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.ORCID 0000-0002-5291-1469
Ed S LeinAllen Institute for Brain Science, Seattle, WA, 98109.ORCID 0000-0001-9012-6552
Allen Institute for Brain Science · USUniversity of Washington · USAllen Institute · USKaiser Permanente Washington Health Research Institute · USChan Zuckerberg Initiative (United States) · USStanford University · US

Funding

Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomicsU19AG060909 · NIA · ALLEN INSTITUTE · PI Jennie Leigh Close, Michael Hawrylycz · 2020 to 2026
$83.6M
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergicsU19AG066567 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Paul K Crane, Andrea Z. LaCroix · 2021 to 2026
$80.4M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI SUMAN JAYADEV · 2020 to 2026
$29.0M
NIA NIH HHS P30 AG066509NIA NIH HHS P50 AG005136NIA NIH HHS U01 AG006781NIA NIH HHS U19 AG060909NIA NIH HHS U19 AG066567
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in older adults. Neuropathological and imaging studies have demonstrated a progressive and stereotyped accumulation of protein aggregates, but the underlying molecular and cellular mechanisms driving AD progression and vulnerable cell populations affected by disease remain coarsely understood. The current study harnesses single cell and spatial genomics tools and knowledge from the BRAIN Initiative Cell Census Network to understand the impact of disease progression on middle temporal gyrus cell types. We used image-based quantitative neuropathology to place 84 donors spanning the spectrum of AD pathology along a continuous disease pseudoprogression score and multiomic technologies to profile single nuclei from each donor, mapping their transcriptomes, epigenomes, and spatial coordinates to a common cell type reference with unprecedented resolution. Temporal analysis of cell-type proportions indicated an early reduction of Somatostatin-expressing neuronal subtypes and a late decrease of supragranular intratelencephalic-projecting excitatory and Parvalbumin-expressing neurons, with increases in disease-associated microglial and astrocytic states. We found complex gene expression differences, ranging from global to cell type-specific effects. These effects showed different temporal patterns indicating diverse cellular perturbations as a function of disease progression. A subset of donors showed a particularly severe cellular and molecular phenotype, which correlated with steeper cognitive decline. We have created a freely available public resource to explore these data and to accelerate progress in AD research at SEA-AD.org.

Identifiers

PMID37292694
PMCPMC10246227
OpenAlexW4377693463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.